Pieris Pharmaceuticals, Inc. financial data

Symbol
PIRS on Nasdaq
Industry
Pharmaceutical Preparations
Location
225 Franklin Street, 26 Th Floor, Boston, Massachusetts
State of incorporation
Nevada
Fiscal year end
December 31
Former names
Marika Inc. (to 12/18/2014)
Latest financial report
Q1 2024 - May 15, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 190 % -22.1%
Debt-to-equity 137 % -22.5%
Return On Equity -86.7 % -5.21%
Return On Assets -30.2 % +28.5%
Operating Margin -47.8 % +84.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 98.9 M shares +32.8%
Common Stock, Shares, Outstanding 1.24 M shares -98.3%
Entity Public Float 11.2 M USD -90.2%
Common Stock, Value, Issued 1 K USD -98.6%
Weighted Average Number of Shares Outstanding, Basic 1.24 M shares +32.9%
Weighted Average Number of Shares Outstanding, Diluted 87.8 M shares +18.5%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 40.9 M USD +143%
Research and Development Expense 29.6 M USD -43.5%
General and Administrative Expense 17 M USD +5.8%
Operating Income (Loss) -19.5 M USD +62.1%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -24.5 M USD +26.2%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -16.3 M USD +60.7%
Earnings Per Share, Basic 9.93 USD/shares +72.1%
Earnings Per Share, Diluted 0.05 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 19.1 M USD -52%
Cash, Cash Equivalents, and Short-term Investments 19.1 M USD -60.5%
Accounts Receivable, after Allowance for Credit Loss, Current 1.84 M USD +74.6%
Assets, Current 38.7 M USD -47.3%
Property, Plant and Equipment, Net 0 USD -100%
Operating Lease, Right-of-Use Asset 0 USD -100%
Other Assets, Noncurrent 0 USD -100%
Assets 29.5 M USD -64.1%
Accounts Payable, Current 1.52 M USD -74%
Employee-related Liabilities, Current 4.19 M USD +150%
Contract with Customer, Liability, Current 0 USD -100%
Liabilities, Current 7.53 M USD -82.4%
Contract with Customer, Liability, Noncurrent 0 USD -100%
Operating Lease, Liability, Noncurrent 0 USD -100%
Other Liabilities, Noncurrent 0 USD
Liabilities 11.9 M USD -82.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax -346 K USD +18.8%
Retained Earnings (Accumulated Deficit) -320 M USD -5.35%
Stockholders' Equity Attributable to Parent 22 M USD +42.1%
Liabilities and Equity 29.5 M USD -64.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -7 M USD +36.4%
Net Cash Provided by (Used in) Financing Activities 19.8 M USD +174%
Net Cash Provided by (Used in) Investing Activities 9 M USD -24.4%
Common Stock, Shares Authorized 3.75 M shares -98.8%
Common Stock, Shares, Issued 1.24 M shares -98.3%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 1.69 M USD +52.5%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 54.3 M USD -54.4%
Deferred Tax Assets, Valuation Allowance 72.5 M USD +19.7%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 72.5 M USD +13.6%
Operating Lease, Liability 12.3 M USD +0.62%
Depreciation 1.8 M USD -21.7%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -16.2 M USD +62.2%
Lessee, Operating Lease, Liability, to be Paid 18.4 M USD -3.37%
Property, Plant and Equipment, Gross 26.7 M USD +3.93%
Operating Lease, Liability, Current 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.09 M USD +7.91%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.09 M USD +7.91%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 0%
Deferred Income Tax Expense (Benefit) 0 USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 6.14 M USD -10.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.09 M USD +7.91%
Deferred Tax Assets, Operating Loss Carryforwards 67.5 M USD +23.1%
Preferred Stock, Shares Issued 15.6 K shares 0%
Deferred Federal Income Tax Expense (Benefit) 0 USD
Current Income Tax Expense (Benefit) 0 USD
Preferred Stock, Shares Authorized 10 M shares 0%
Unrecognized Tax Benefits 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.09 M USD +7.91%
Operating Lease, Payments 1.7 M USD -26.1%
Additional Paid in Capital 342 M USD +7.12%
Preferred Stock, Shares Outstanding 15.6 K shares
Current State and Local Tax Expense (Benefit) 0 USD
Current Federal Tax Expense (Benefit) 0 USD
Depreciation, Depletion and Amortization 1.9 M USD -31.3%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 3.35 M USD -23.9%
Deferred State and Local Income Tax Expense (Benefit) 0 USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%